Table of Content

1 Study Coverage
1.1 Montelukast Drug Product Introduction
1.2 Market by Type
1.2.1 Global Montelukast Drug Market Size Growth Rate by Type, 2018 VS 2023 VS 2029
1.3 Market by Application
1.3.1 Global Montelukast Drug Market Size Growth Rate by Application, 2018 VS 2023 VS 2029
1.4 Global Montelukast Drug Market by Region
1.4.1 Global Montelukast Drug Market by Region: 2018 VS 2023 VS 2029
1.4.2 Global Montelukast Drug Revenue Market
1.5 Study Objectives
1.6 Years Considered
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
1.9 Coronavirus Disease (COVID-19) Impact on Global
2 Competition by Players
2.1 Global Montelukast Drug Revenue by Players
2.1.1 Global Montelukast Drug Revenue by Players (2018-2023)
2.1.2 Global Montelukast Drug Revenue Market Share by Players (2018-2023)
2.1.3 Global Top 5 and Top 10 Companies by Montelukast Drug Revenue in 2023
2.2 Global Montelukast Drug Gross Margin by Players
2.3 Analysis of Competitive Landscape
2.3.1 Players Market Concentration Ratio (CR5)
2.3.2 Global Montelukast Drug Players Geographical Distribution
2.4 Mergers & Acquisitions, Expansion Plans
3 Company Overview
3.1 Merck & Co.
3.1.1 Merck & Co. Information
3.1.2 Merck & Co. Overview
3.1.3 Merck & Co. Montelukast Drug Revenue and Gross Margin (2018-2023)
3.1.4 Merck & Co. Related Developments
3.2 Teva
3.2.1 Teva Information
3.2.2 Teva Overview
3.2.3 Teva Montelukast Drug Revenue and Gross Margin (2018-2023)
3.2.4 Teva Related Developments
3.3 Mylan
3.3.1 Mylan Information
3.3.2 Mylan Overview
3.3.3 Mylan Montelukast Drug Revenue and Gross Margin (2018-2023)
3.3.4 Mylan Related Developments
3.4 Glenmark Pharmaceuticals
3.4.1 Glenmark Pharmaceuticals Information
3.4.2 Glenmark Pharmaceuticals Overview
3.4.3 Glenmark Pharmaceuticals Montelukast Drug Revenue and Gross Margin (2018-2023)
3.4.4 Glenmark Pharmaceuticals Related Developments
3.5 Hikma Group
3.5.1 Hikma Group Information
3.5.2 Hikma Group Overview
3.5.3 Hikma Group Montelukast Drug Revenue and Gross Margin (2018-2023)
3.5.4 Hikma Group Related Developments
3.6 Sandoz
3.6.1 Sandoz Information
3.6.2 Sandoz Overview
3.6.3 Sandoz Montelukast Drug Revenue and Gross Margin (2018-2023)
3.6.4 Sandoz Related Developments
3.7 Torrent Pharmaceuticals
3.7.1 Torrent Pharmaceuticals Information
3.7.2 Torrent Pharmaceuticals Overview
3.7.3 Torrent Pharmaceuticals Montelukast Drug Revenue and Gross Margin (2018-2023)
3.7.4 Torrent Pharmaceuticals Related Developments
3.8 Lannett Company
3.8.1 Lannett Company Information
3.8.2 Lannett Company Overview
3.8.3 Lannett Company Montelukast Drug Revenue and Gross Margin (2018-2023)
3.8.4 Lannett Company Related Developments
3.9 Apotex
3.9.1 Apotex Information
3.9.2 Apotex Overview
3.9.3 Apotex Montelukast Drug Revenue and Gross Margin (2018-2023)
3.9.4 Apotex Related Developments
3.10 Dr. Reddys Laboratories
3.10.1 Dr. Reddys Laboratories Information
3.10.2 Dr. Reddys Laboratories Overview
3.10.3 Dr. Reddys Laboratories Montelukast Drug Revenue and Gross Margin (2018-2023)
3.10.4 Dr. Reddys Laboratories Related Developments
3.11 Aurobindo Pharma
3.11.1 Aurobindo Pharma Information
3.11.2 Aurobindo Pharma Overview
3.11.3 Aurobindo Pharma Montelukast Drug Revenue and Gross Margin (2018-2023)
3.11.4 Aurobindo Pharma Related Developments
3.12 Accord Healthcare
3.12.1 Accord Healthcare Information
3.12.2 Accord Healthcare Overview
3.12.3 Accord Healthcare Montelukast Drug Revenue and Gross Margin (2018-2023)
3.12.4 Accord Healthcare Related Developments
3.13 Hetero
3.13.1 Hetero Information
3.13.2 Hetero Overview
3.13.3 Hetero Montelukast Drug Revenue and Gross Margin (2018-2023)
3.13.4 Hetero Related Developments
3.14 Unimark
3.14.1 Unimark Information
3.14.2 Unimark Overview
3.14.3 Unimark Montelukast Drug Revenue and Gross Margin (2018-2023)
3.14.4 Unimark Related Developments
3.15 Ajanta Pharma
3.15.1 Ajanta Pharma Information
3.15.2 Ajanta Pharma Overview
3.15.3 Ajanta Pharma Montelukast Drug Revenue and Gross Margin (2018-2023)
3.15.4 Ajanta Pharma Related Developments
3.16 MACLEODS
3.16.1 MACLEODS Information
3.16.2 MACLEODS Overview
3.16.3 MACLEODS Montelukast Drug Revenue and Gross Margin (2018-2023)
3.16.4 MACLEODS Related Developments
3.17 Jubilant Pharma
3.17.1 Jubilant Pharma Information
3.17.2 Jubilant Pharma Overview
3.17.3 Jubilant Pharma Montelukast Drug Revenue and Gross Margin (2018-2023)
3.17.4 Jubilant Pharma Related Developments
3.18 Unichem Laboratories
3.18.1 Unichem Laboratories Information
3.18.2 Unichem Laboratories Overview
3.18.3 Unichem Laboratories Montelukast Drug Revenue and Gross Margin (2018-2023)
3.18.4 Unichem Laboratories Related Developments
3.19 Amneal Pharmaceuticals
3.19.1 Amneal Pharmaceuticals Information
3.19.2 Amneal Pharmaceuticals Overview
3.19.3 Amneal Pharmaceuticals Montelukast Drug Revenue and Gross Margin (2018-2023)
3.19.4 Amneal Pharmaceuticals Related Developments
3.20 Shanghai Anbison Lab
3.20.1 Shanghai Anbison Lab Information
3.20.2 Shanghai Anbison Lab Overview
3.20.3 Shanghai Anbison Lab Montelukast Drug Revenue and Gross Margin (2018-2023)
3.20.4 Shanghai Anbison Lab Related Developments
3.21 Perrigo
3.21.1 Perrigo Information
3.21.2 Perrigo Overview
3.21.3 Perrigo Montelukast Drug Revenue and Gross Margin (2018-2023)
3.21.4 Perrigo Related Developments
3.22 Cipla
3.22.1 Cipla Information
3.22.2 Cipla Overview
3.22.3 Cipla Montelukast Drug Revenue and Gross Margin (2018-2023)
3.22.4 Cipla Related Developments
3.23 CSPC Ouyi Pharmaceutical
3.23.1 CSPC Ouyi Pharmaceutical Information
3.23.2 CSPC Ouyi Pharmaceutical Overview
3.23.3 CSPC Ouyi Pharmaceutical Montelukast Drug Revenue and Gross Margin (2018-2023)
3.23.4 CSPC Ouyi Pharmaceutical Related Developments
4 Global Montelukast Drug Market Insights
4.1 Global Montelukast Drug Market Revenue 2018-2023
4.2 Global Montelukast Drug Revenue by Region
4.3 Americas
4.4 Europe
4.5 Asia-Pacific
4.6 Middle East & Africa
5 Market Size by Type
5.1 Global Montelukast Drug Revenue by Type
5.2 Global Montelukast Drug Market Size Growth by Type 2018-2023
6 Market Size by Application
6.1 Global Montelukast Drug Revenue by Application
6.2 Global Montelukast Drug Market Size Growth by Application 2018-2023
7 Americas
7.1 Americas Montelukast Drug Market Size by Type
7.1.1 Americas Montelukast Drug Revenue by Type (2018-2023)
7.1.2 Americas Montelukast Drug Revenue Share by Type (2018-2023)
7.2 Americas Montelukast Drug Market Size by Application
7.2.1 Americas Montelukast Drug Revenue by Application (2018-2023)
7.2.2 Americas Montelukast Drug Revenue Share by Application (2018-2023)
7.3 Americas Montelukast Drug Market Size by Country
7.3.1 Americas Montelukast Drug Revenue by Country (2018-2023)
7.3.2 U.S.
7.3.3 Canada
7.3.4 Mexico
7.3.5 Brazil
7.3.6 Argentina
8 Europe
8.1 Europe Montelukast Drug Market Size by Type
8.1.1 Europe Montelukast Drug Revenue by Type (2018-2023)
8.1.2 Europe Montelukast Drug Revenue Share by Type (2018-2023)
8.2 Europe Montelukast Drug Market Size by Application
8.2.1 Europe Montelukast Drug Revenue by Application (2018-2023)
8.2.2 Europe Montelukast Drug Revenue Share by Application (2018-2023)
8.3 Europe Montelukast Drug Market Size by Country
8.3.1 Europe Montelukast Drug Revenue by Country (2018-2023)
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
9 Asia Pacific
9.1 Asia Pacific Montelukast Drug Market Size by Type
9.1.1 Asia Pacific Montelukast Drug Revenue by Type (2018-2023)
9.1.2 Asia Pacific Montelukast Drug Revenue Share by Type (2018-2023)
9.2 Asia Pacific Montelukast Drug Market Size by Application
9.2.1 Asia Pacific Montelukast Drug Revenue by Application (2018-2023)
9.2.2 Asia Pacific Montelukast Drug Revenue Share by Application (2018-2023)
9.3 Asia Pacific Montelukast Drug Market Size by Region
9.3.1 Asia Pacific Montelukast Drug Revenue by Region (2018-2023)
9.3.2 China
9.3.3 Japan
9.3.4 South Korea
9.3.5 India
9.3.6 Southeast Asia
9.3.7 Australia
10 Middle East and Africa
10.1 Middle East and Africa Montelukast Drug Market Size by Type
10.1.1 Middle East and Africa Montelukast Drug Revenue by Type (2018-2023)
10.1.2 Middle East and Africa Montelukast Drug Revenue Share by Type (2018-2023)
10.2 Middle East and Africa Montelukast Drug Market Size by Application
10.2.1 Middle East and Africa Montelukast Drug Revenue by Application (2018-2023)
10.2.2 Middle East and Africa Montelukast Drug Revenue Share by Application (2018-2023)
10.3 Middle East and Africa Montelukast Drug Market Size by Country
10.3.1 Middle East and Africa Montelukast Drug Revenue by Country (2018-2023)
10.3.2 Turkey
10.3.3 Saudi Arabia
10.3.4 U.A.E
11 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
11.1 Montelukast Drug Industry Trends
11.2 Montelukast Drug Market Drivers
11.3 Montelukast Drug Market Challenges
11.4 Montelukast Drug Market Restraints
12 Montelukast Drug Forecasted Market Size by Type
12.1 Global Montelukast Drug Forecasted Revenue by Type
12.2 Global Montelukast Drug Forecasted Market Size Growth by Type 2023-2029
13 Montelukast Drug Forecasted Market Size by Application
13.1 Global Montelukast Drug Forecasted Revenue by Application
13.2 Global Montelukast Drug Forecasted Market Size Growth by Application 2023-2029
14 Global Montelukast Drug Market Forecasts
14.1 Global Montelukast Drug Market Revenue Forecasts 2023-2029
14.2 Global Montelukast Drug Forecasts Revenue by Region
14.3 Americas
14.3.1 Americas Montelukast Drug Forecasts Revenue by Country (2018-2023)
14.4 Europe
14.4.1 Europe Montelukast Drug Forecasts Revenue by Country (2018-2023)
14.5 Asia-Pacific
14.5.1 Asia Pacific Montelukast Drug Forecasts Revenue by Country (2018-2023)
14.6 Middle East & Africa
14.6.1 Middle East and Africa Montelukast Drug Forecasts Revenue by Country (2018-2023)
15 Research Findings and Conclusion
16 Methodology and Data Source
16.1 Methodology
16.1.1 Research Process
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Legal Disclaimer